| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apimeds Pharmaceuticals Us, Inc. (APUS) has 7 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. APUS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 215.0K | $281.6K | - | |
| Dir | 10.0K | $13.1K | - | |
| Dir | 10.0K | $13.1K | - | |
| Dir | 10.0K | $13.1K | - | |
| Dir | 10.0K | $13.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Kim Christopher | Chairman And CMO | Buy | 27,500 | $1.83 | $50,359.20 | +139.1% | -13.4% | - | |
| May 12, 2025 | Inscobee Inc. | 10% Owner | Buy | 500,000 | $4.00 | $2,000,000.00 | +33.7% | -15.5% | -16.4% | |
| May 12, 2025 | Koo Jakap | Director | Buy | 28,500 | $1.99 | $56,715.00 | +4.6% | -15.5% | -16.4% |